Informações:
Falhas:
ID
20072
Descrição
Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate; ODM derived from: https://clinicaltrials.gov/show/NCT00440648
Link
https://clinicaltrials.gov/show/NCT00440648
Palavras-chave
Versões (1)
- 05/02/2017 05/02/2017 -
Transferido a
5 de fevereiro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Chronic Kidney Disease NCT00440648
Eligibility Chronic Kidney Disease NCT00440648
- StudyEvent: Eligibility
Similar models
Eligibility Chronic Kidney Disease NCT00440648
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Hemodialysis Frequency Duration
Item
patient had received hemodialysis three times per week for 3 months or longer;
boolean
C0019004 (UMLS CUI [1,1])
C0376249 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0376249 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Sevelamer hydrochloride Daily Dose | Phosphate Binder Primary | serum phosphorus measurement Quantity | Intact Parathyroid Hormone Measurement | Serum calcium normal
Item
patients were maintained on sevelamer hydrochloride as their primary phosphate binder with a total daily dose of ≤ 13.6 g with serum phosphorus concentrations at the last two measurements between 3.0 and 6.5 mg/dl, the most recent ipth ≤ 600 pg/ml and the most recent serum calcium within the normal range.
boolean
C0772463 (UMLS CUI [1,1])
C2348070 (UMLS CUI [1,2])
C2267031 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C2229833 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C2697755 (UMLS CUI [4])
C0858094 (UMLS CUI [5])
C2348070 (UMLS CUI [1,2])
C2267031 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C2229833 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C2697755 (UMLS CUI [4])
C0858094 (UMLS CUI [5])
Intestinal Obstruction | Deglutition Disorders | Gastrointestinal motility disorder Severe
Item
if patient had active bowel obstruction, dysphagia, swallowing disorders, or severe gastrointestinal motility disorders;
boolean
C0021843 (UMLS CUI [1])
C0011168 (UMLS CUI [2])
C0854121 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0011168 (UMLS CUI [2])
C0854121 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Substance Use Disorders | Tobacco Use Disorder
Item
active ethanol or drug abuse (excluding tobacco);
boolean
C0038586 (UMLS CUI [1])
C0040336 (UMLS CUI [2])
C0040336 (UMLS CUI [2])
Pharmaceutical Preparations Against Cardiac Arrhythmia Patient need for | Anticonvulsants Patient need for
Item
need for antidysrhythmic or antiseizure medications used to control these conditions;
boolean
C0013227 (UMLS CUI [1,1])
C0521124 (UMLS CUI [1,2])
C0003811 (UMLS CUI [1,3])
C0686904 (UMLS CUI [1,4])
C0003286 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
C0521124 (UMLS CUI [1,2])
C0003811 (UMLS CUI [1,3])
C0686904 (UMLS CUI [1,4])
C0003286 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
poorly controlled diabetes mellitus | Hypertensive disease Poorly controlled
Item
poorly controlled diabetes mellitus or hypertension;
boolean
C0554876 (UMLS CUI [1])
C0020538 (UMLS CUI [2,1])
C3853134 (UMLS CUI [2,2])
C0020538 (UMLS CUI [2,1])
C3853134 (UMLS CUI [2,2])
Vasculitis
Item
active vasculitis;
boolean
C0042384 (UMLS CUI [1])
Malignant Neoplasms | Basal cell carcinoma
Item
active malignancy other than basal-cell carcinoma;
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0007117 (UMLS CUI [2])
HIV Infection
Item
hiv infection; or
boolean
C0019693 (UMLS CUI [1])
Medical condition Unstable Clinical Significance
Item
any clinically significant unstable medical condition as judge by the investigator.
boolean
C3843040 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
C0443343 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])